Patent Infringement Settled and Discontinued

RNS Number : 5312W
Revolymer PLC
10 November 2014
 



10 November 2014

Revolymer plc

("Revolymer" or "the Company")

Notice of Settlement and Discontinuation of Patent Infringement Proceedings

 

In respect of the alleged patent infringement action brought by Fertin Pharma A/S and Gumlink A/S against the Company relating to the sale of its nicotine gum products in Canada (the "Action"), Revolymer is pleased to announce that the Action, and the counterclaim forming part of Revolymer's defence, has been settled and discontinued.

 

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Kevin Matthews / Rob Cridland

 


Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Hugh Morgan / Adam James (Corporate Finance)

Charles Leigh-Pemberton (Corporate Broking)


Citigate Dewe Rogerson

+44 (0)20 7282 2867

David Dible / Malcolm Robertson

 


 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within the global high value FMCG industry. Current applications for the Group's technologies are in the coatings & adhesives, household products and personal care markets (together "Consumer Specialties") and the confectionery chewing gum and medicated chewing gum (together "Gum") markets.

www.revolymer.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMGMLLZGDZM

Companies

Itaconix (ITX)
UK 100

Latest directors dealings